miRNAs regulate SIRT1 expression during mouse embryonic stem cell









































As multicellular organisms age, somatic tissues show 
evidence of genomic instability and an increased error 
rate in protein synthesis. In contrast, the germ line is 
protected from genomic instability to ensure the 
ultimate survival of its genome. As the disposable soma 
theory of aging suggests, maintaining a low error rate is 
energy intensive, so somatic cells may trade off a high 
level of accuracy to save energy, leading to instability 
and eventually error catastrophe in aging somatic cells 
[1]. As embryonic stem cells (ESCs) can differentiate 
into all cell types, including the germ line, they must 
expend energy to maintain the genome and repair 
damage.  Multiple  stress defense mechanisms,  such  as  
 
 





































telomere maintenance, antioxidant function, and DNA 
repair, are highly active in ESCs and downregulated 
during differentiation [2].   
 
SIRT1 protects against age-related diseases by 
deacetylating targets (e.g., p53, FOXO, NFκB, and 
PGC-1α) that regulate diverse cellular processes, 
including stress response, replicative senescence, 
inflammation, and metabolism [3-4]. SIRT1 protein 
levels are high in mouse embryonic stem cells [5-6] and 
participates in the defense against oxidative stress in 
these cells [7]. Several Caenorhabditis elegans genes 
that ensure the genomic integrity of the germ line are 
also involved in regulating lifespan although it is not 






































pluripotent  stem  (iPS)  cells.  The  regulation  of  SIRT1  protein  levels  by  miRNAs  might  provide  new  opportunities  for
therapeutic tissue‐specific modulation of SIRT1 expression and for reprogramming of somatic cells into iPS cells.  
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SIRT1, regulates lifespan [9],SIRT1 may be a gene 
whose high-level expression in the germ line and ESCs 
maintains genomic integrity and plays a key role in 
regulating lifespan.  
 
SIRT1 is critical for development: loss of both SIRT1 
alleles in mice leads to postnatal lethality. Mice lacking 
SIRT1 survive when outbred but yield smaller, sterile 
mice with developmental defects [10-11]. In addition, 
SIRT1 expression is induced during calorie restriction 
(CR), a 20-40% lowering of caloric intake that extends 
lifespan [12]. Transgenic mice that overexpress SIRT1 
partially phenocopy CR [13], and are protected from 
age-related diseases such as diabetes, osteoporosis, and 
cancer [14]. SIRT1
-/- mice do not have a longer lifespan 
on a CR diet [15]. Resveratrol, a polyphenol from 
grapes, works via the SIRT1 pathway to extend the 
lifespan of older mice fed a high-fat diet [16]. Similar to 
resveratrol, small-molecule activators of SIRT1 mimic 
the beneficial effects of CR and protect mice against 
age-related diseases [17-18].  
 
These observations highlight the importance of tightly 
regulating SIRT1 and the benefits of increasing SIRT1 
expression and activity to promote longevity and 
suppress age-related diseases. Tight regulation of 
SIRT1 expression and activity is achieved through 
regulation of transcription by p53, FOXO3a, and E2F1 
[19-20]. SIRT1 expression is also regulated by 
controlling mRNA stability by HuR [21] and its 
enzymatic activity is sensitive to cellular NAD
+ levels 
[22-23]. SIRT1-interacting proteins such as DBC1 and 
AROS also regulate its activity [24-25].  
 
Here we report that SIRT1 is highly expressed in 
mESCs compared to differentiated tissues and identify 
several miRNAs that regulate its expression at a post-




SIRT1 protein is expressed at high levels in mESCs 
and post-transcriptionally downregulated during 
differentiation 
 
We observed that SIRT1 protein levels are higher in 
mESCs than differentiated mouse tissues (Figure 1A). 
Overloading of lysate from differentiated tissues and a 
different SIRT1 antibody confirmed ubiquitous 
expression of SIRT1 in differentiated tissues, however 
expression was significantly lower than in mESCs 
(Figure 1A, lower panel). HDAC1 protein levels were 
also higher in mESCs, whereas HDAC2 protein 
expression was similar in mESCs and differentiated 
tissues (Figure 1A). Strikingly, measurement of SIRT1 
mRNA levels by quantitative reverse transcription-PCR 
(qRT-PCR) showed relatively similar levels in mESCs 
and differentiated mouse tissues, except for skin and 
testis where mRNA levels were significantly higher 
(Figure 1B). In contrast, HDAC1 and HDAC2 mRNA 
correlated more closely with protein expression: 
HDAC1 mRNA levels were much lower (5−15 fold) in 
most differentiated tissues than in mESCs, whereas 
HDAC2 mRNA levels were similar in mESCs and 
differentiated tissues (Figure 1B). These findings of 
discordant mRNA and protein levels of SIRT1 
suggested that SIRT1 is regulated post-transcriptionally 
in most adult mouse tissues.  
 
To determine if SIRT1 is also regulated post-
transcriptionally during in vitro differentiation of 
mESCs, we removed leukemia inhibitory factor (LIF) 
from the culture medium to allow the cells to 
differentiate into embryoid bodies. Protein and RNA 
were isolated from the mESCs and embryoid bodies 
every two days during in vitro differentiation. At d6 of 
the differentiation process, the high SIRT1 protein 
levels found in undifferentiated mESCs began to 
decrease (Figure 1C). Control mESCs cultured under 
non-differentiating conditions showed no change in 
SIRT1 expression (Figure 1C, right panel). In addition, 
SIRT1 protein expression levels decreased during 
directed differentiation of mESCs into neurons 
(Supplementary Figure S1). HDAC1 and HDAC4 
expression were high in mESCs and decreased late 
during differentiation with kinetics distinct from that of 
SIRT1 (Figure 1C). In contrast, HDAC2 protein levels 
remained constant during in vitro differentiation. As 
expected, markers of pluripotency, including Nanog, 
Sox2, and Oct-3/4, were expressed in mESCs and 
decreased early during differentiation (Figure 1C and 
data not shown). In embryoid bodies, which exhibit 
spontaneous neural differentiation, the neuronal 
precursor marker Nestin was transiently induced, 
whereas Tau, a marker of mature neurons, was induced 
at late differentiation stages (Figure 1C).  
 
In contrast to the decrease in SIRT1 protein levels 
observed during in vitro differentiation of mESCs, 
SIRT1 mRNA levels showed no change (Figure 1D, left 
panel). HDAC2 mRNA levels mirrored protein levels 
and were unchanged during differentiation. mRNAs 
levels of pluripotent stem cell markers, including Oct-
3/4 (Figure 1D, left panel), Nanog, and Sox2 (data not 
shown) decreased during differentiation. mRNA 
expression of the ectoderm marker Map2 and the 
endoderm marker FoxA2 increased during 
differentiation, and Nestin mRNA expression 
transiently increased (Figure 1D, right panel).  
   




















































































































































































































































transfection.  Data  are  representative  of  three  experiments.  (G)  qRT‐PCR  analysis  confirmed  Dicer  knockdown  and  no
significant change in SIRT1 mRNA levels. Data are mean ± s.d. for three samples. 
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regulates SIRT1 expression 
 
To examine the mechanism of SIRT1 post-
transcriptional regulation, we first tested whether SIRT1 
protein stability is controlled by the proteasome. As a 
positive control, we confirmed that REST, an essential 
protein in undifferentiated mESCs that represses 
neuronal genes in differentiated non-neuronal tissues, 
was downregulated by the proteasome during 
differentiation as previously reported [26]. Treatment of 
d8 embryoid bodies with the proteasome inhibitor MG-
132 increased REST protein expression; however, in the 
same cell culture population, proteasome inhibition did 
not increase SIRT1 protein expression (Figure 2A and 
B; Supplementary Figure S2). Thus, proteasome-
mediated degradation of SIRT1 is not responsible for its 
post-transcriptional downregulation during differentia-
tion.  
 
We next determined if SIRT1 is subject to post-
transcriptional regulation by miRNAs [27]. For this 
purpose, we inactivated Dicer, an enzyme required for 
processing of small RNAs, including miRNAs, into 
their mature functional form [28]. We injected 
Dicer
flox/flox mice [29] with an adeno-associated viral 
(AAV) vector expressing Cre from the hepatocyte-
specific transthyretin promoter. Liver-specific 
inactivation of Dicer increased SIRT1 protein levels 
(Figure 2C, D) while SIRT1 mRNA levels slightly 
decreased (Figure 2E). Additionally, we isolated lung 
fibroblasts from the Dicer
flox/flox mice and infected them 
with an adenovirus expressing Cre or GFP. Cre-
mediated inactivation of Dicer increased SIRT1 protein 
levels (Figure 2F, G), without changing SIRT1 mRNA 
levels (Figure 2H). To determine whether miRNAs or 
other small RNAs regulate SIRT1 in differentiated 
tissues, we knocked down the expression of DGCR8, 
which is specifically required for processing of 
miRNAs, and Dicer in mouse NIH3T3 cells. 
Knockdown of either DGCR8 or Dicer increased SIRT1 
protein expression (Figure 2I, J) without changing 
SIRT1 mRNA levels (Figure 2K). Knockdown of Dicer 
was verified by qRT-PCR mRNA measurement and 
knockdown of DGCR8 was verified by western blot 
(Figure 2 I-K). Thus, miRNAs post-transcriptionally 
regulate SIRT1 in differentiated tissues and cell lines, 
and may account for the downregulation of SIRT1 
during in vitro mESC differentiation. 
 
The SIRT1 mRNA 3'-UTR is targeted by multiple 
miRNAs 
 
To identify miRNAs that target SIRT1, we examined 
the 1.6-kb mSIRT1 3'-UTR with algorithms that predict 
miRNA target sites [30-31]. Target Scan 5.1 revealed 
22 miRNAs targeting 12 broadly conserved seed sites in 
the 3'-UTR of mSIRT1. This analysis also revealed two 
miRNAs targeting three seed sites conserved only in 
mammals, and 66 seed sites for poorly conserved 
miRNA families. In contrast, HDAC1, which has a 
shorter 3'-UTR (0.5 kb), had no broadly conserved 
miRNA seed sites, one seed site conserved in mammals, 
and 22 seed sites for poorly conserved miRNAs (data 
not shown). We hypothesized that if miRNAs post-
transcriptionally downregulate SIRT1 during mESC 
differentiation, the miRNAs responsible should be 
induced during differentiation when SIRT1 protein 
levels are decreased. We used qRT-PCR to profile the 
expression of 39 miRNAs that potentially target SIRT1: 
21 well-conserved miRNAs (representing 11 miRNA 
families), two miRNAs conserved only in mammals, 
and 16 less conserved miRNAs many of which had two 
target sites in the 3'-UTR of mSIRT1 (Supplementary 
Table 1). We found that 18 miRNAs from nine families 
were upregulated 30–5000 fold during mESC 
differentiation (Figure 3A). The expression of six 
selected miRNAs during mESC differentiation is 
illustrated in Figure 3B,C.  
 
miR-181a and b, miR-9, miR-204, miR-135a, and 
miR-199b target endogenous SIRT1 
 
To identify miRNAs that post-transcriptionally regulate 
SIRT1, we cloned the 1.6-kb mSIRT1 3'-UTR 
downstream of luciferase, and transfected this construct 
(pGL3-SIRT1 3'-UTR) into mESCs along with miRNA 
mimics or miRNA expression constructs, and measured 
luciferase activity 24 h later. We found that miR-181a, 
b, and c repressed luciferase activity by 25–30% (Figure 
4A, left panel). The specificity of this inhibition was 
demonstrated by testing the effect of the same miRNAs 
on a construct in which the miR-181 seed-binding site 
was mutated (pGL3-SIRT1 3'-UTR 181mt; Figure 4A, 
left panel). Likewise, co-transfection of a miR-9 
expression vector repressed luciferase activity of pGL3-
SIRT1 3'-UTR by 30% but not pGL3-SIRT1 3'-UTR 
9mt, a control construct with a mutated miR-9 binding 
site (Figure 4A, right panel). Thus, miR-181 family 
members and miR-9 target the 3'-UTR of SIRT1 
through the predicted seed sites.  
 
To directly confirm the ability of select miRNAs to target 
the 3'-UTR of endogenous SIRT1, candidate miRNAs 
were introduced into mESCs and SIRT1 protein levels 
were assessed. Overexpression of miR-181a and b, miR-
9, miR-204, miR-135a, and miR-199b decreased SIRT1 
protein levels in mESCs (Figure 4B). In contrast, 
overexpression of miR-1, a miRNA not predicted to 
target the SIRT1 3'-UTR, did not decrease SIRT1 protein 
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upon miRNA overexpression, and the expression of 




















































miRNAs (Figure 4C). These data confirm that miR-181a 
and b, miR-9, miR-204, miR-135a, and miR-199b target 























































were  induced  during  mESC  differentiation  at  the  time  SIRT1  protein  was  downregulated.  Their  fold
induction in d20 embryoid bodies above their expression in undifferentiated mESCs was plotted on the y‐
axis, and the location of their seed binding site in the 3'‐UTR of mSIRT1 was plotted on the x‐axis. (B−C),
qRT‐PCR  of  miRNA  expression  relative  to  miR‐16  from  undifferentiated  mESCs  and  differentiating
embryoid bodies of specific miRNAs that potentially target SIRT1. Data are mean ± s.d. for four samples. 
   











































Inhibition of miR-9 prevents the downregulation of 
SIRT1 protein expression during differentiation 
 
We consistently observed that miR-9 was the first 
SIRT1-targeting miRNA to be upregulated both during 
differentiation of mESCs into embryoid bodies (Figure 
3B) and during the directed differentiation of mESCs 
into neurons (data not shown). miR-9 is expressed in the 
brain, induced during differentiation of neuronal 
precursors into neurons, and regulates neural lineage 
differentiation [32]. To confirm that miR-9 represses 












































whether inhibition of miR-9 prevents the downregulation 
of SIRT1 protein. We used a FITC-labelled locked 
nucleic acid (LNA)-probe antisense to miR-9 to block 
miR-9 activity (LNA-miR-9). LNA-miR-9 or a 
scrambled control (LNA-SCR) was transfected into 
embryoid bodies at d4 and d7. Only cells on the outer 
layer of the embryoid bodies were transfected by this 
method, and fluorescence microscopy estimated that 
~35% of cells were FITC
+ (data not shown). As 
expected, miR-9 expression strongly increased during 
differentiation (Figure 5A). LNA-miR-9 reduced 
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mRNA expression (Figure 5B). Importantly, LNA-miR-
9, but not LNA-SCR or untransfected controls, 




















































pression of SIRT1 protein (Figure 5C). Thus, of the 17 
miRNAs upregulated during mESC differentiation that 
potentially target SIRT1, miR-9 acts early during 
















































































































To enhance the fraction of cells transfected, we 
dissociated d6 embryoid bodies, transfected them with 
LNA-miR-9 or LNA-SCR, reaggregated the embryoid 
bodies, and assessed SIRT1 expression at d11. With this 
method, 70–80% of the cells in the embryoid bodies 
were transfected, and LNA-miR-9 specifically increased 
SIRT1 protein levels ~two-fold (Figure 5D) qRT-PCR 
analysis demonstrated a more efficient repression of 
miR-9 expression in the LNA-miR-9 treated cells 
(Figure 5E), with minimal change in SIRT1 mRNA 
levels (Figure 5F). These observations confirmed that 
miR-9 inhibition increased SIRT1 protein levels.  
 
SIRT1 protein levels increase during 
reprogramming 
 
As SIRT1 protein levels are lower in differentiated 
tissues than in mESCs, we next asked if SIRT1 protein 
levels increase during reprogramming of mouse 
embryonic fibroblasts (MEFs) into induced pluripotent 
stem (iPS) cells. We used previously described iPS cell 
lines derived from retroviral mediated expression of 
Oct-3/4, Sox2, Klf4, and c-myc in MEFs. These iPS cell 
lines also express a Nanog-GFP reporter [33]. Protein 
levels of SIRT1 were low in the starting MEFs and were 
dramatically upregulated in iPS clones, to the same 
levels seen in two mESC lines, E14 and RF8 (Figure 
6A, B). Similarly, low levels of HDAC1 protein were 
upregulated during reprogramming of MEFs into iPS, 
while HDAC2 protein levels were broadly similar in 
MEFs, iPS, and mESCs (Figure 6A, B). Comparison of 
SIRT1 mRNA levels in mESCs, MEFs, and iPS clones 
showed that the starting MEFs had only 30% of the 
SIRT1 mRNA, but this only partially explains the 6.5-
fold difference in SIRT1 protein expression (Figure 
6C). Thus, post-transcriptional regulation of SIRT1 
contributes significantly to the upregulation of SIRT1 
protein levels during reprogramming. 
 
To identify miRNAs that may post-transcriptionally 
upregulate SIRT1 protein during reprogramming, 
expression levels of miRNAs that potentially target 
SIRT1 were compared in mESCs, MEFs, and iPS cells. 
As previously discussed, miR-199a and b were strongly 
upregulated during mESC differentiation (Figure 3). As 
predicted, reprogramming of MEFs into iPS cells was 
accompanied by a downregulation of miR-199a and b 
by 3.3–fold and 5.8–fold, respectively (Figure 6D). 
Additionally, all five members of the miR-30 family 
that potentially target SIRT1 were higher in MEFs than 
iPS and mESCs. Therefore, expression of select 
miRNAs, including the miR-199 and miR-30 families, 
decreases during reprogramming and may allow for the 




Our work shows that SIRT1 is highly expressed in 
mESCs and that miRNAs post-transcriptionally 
downregulate SIRT1 protein expression during mESC 
differentiation and maintain low SIRT1 protein levels in 
differentiated adult mouse tissues. Specifically, SIRT1 
Figure  6.  SIRT1  protein  levels  are  upregulated  during
reprogramming. (A) mESCs, MEFs, and iPS cells were subject
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miR-204, miR-135a, and miR-199b.  
 
Repression of SIRT1 protein expression by miRNAs 
may play an important role in development since 
several miRNAs that target SIRT1 have previously been 
identified as regulators of specific differentiation 
pathways. For example, miR-9, a miRNA expressed 
early during mESC differentiation, participates in 
neuronal differentiation [32]. Since activation of SIRT1 
in neuronal precursors promotes astrocyte formation 
over neurogenesis [34], SIRT1 might represent a critical 
target for miR-9. Another similar example is miR-181, 
which is transiently upregulated during muscle 
differentiation [35]. SIRT1 inhibition induces premature 
differentiation of C2C12 myoblasts, and SIRT1 
activation inhibits muscle differentiation [36]. Thus, 
regulation of SIRT1 by miR-181 might contribute to the 
muscle differentiation program. miR-181a also 
regulates T-cell-receptor sensitivity and signal strength 
during T-cell development, in part by targeting tyrosine 
phosphatases [37]. Since SIRT1 inhibition induces T-
cell hyperactivation [38], miR-181a may also target 
SIRT1 during T cell development.  
 
Because each miRNA targets only one site in the 
SIRT1 3'-UTR, multiple tissue-specific miRNAs likely 
work together to regulate SIRT1 expression. 
Additionally, miRNA regulation of SIRT1 might be 
influenced by HuR [39], which binds the 3'-UTR and 
stabilizes the SIRT1 transcript [21], even though HuR 
binding sites do not directly overlap miRNA seed-
binding sites in the SIRT1 3'-UTR. HuR, whose 
expression decreases during aging, is targeted by miR-
519, which triggers senescence and represses tumor 
growth through downregulation of HuR [40-41]. 
Tissue-specific therapeutic targeting of miRNAs that 
regulate SIRT1 might allow the selective upregulation 
of SIRT1 in unique tissues, whereas current small 
molecules that activate SIRT1 do so in a tissue non-
specific manner. 
 
We also tested whether SIRT1 protein levels might 
increase upon reprogramming of MEFs into iPS cells. 
Remarkably, we found that low SIRT1 protein levels in 
MEFs were upregulated during reprogramming into iPS 
cells to levels similar to mESCs (Figure 6A). This 
correlated with the downregulation of miR-199 and miR-
30 families that target SIRT1 (Figure 6C). Expression of 
miR-199a and b is highest in skin (Supplementary Figure 
S3), and limiting the expression of these specific 
miRNAs may be a prerequisite for reprogramming of 
MEFs. Reprogramming of other differentiated cell types 
may require downregulation of distinct tissue-specific 
miRNAs that regulate SIRT1 expression. 
An important area for future focus will be to understand  
why SIRT1 protein levels are exceptionally high in 
mESCs. SIRT1 might be required to maintain a unique 
chromatin state in ESCs, or to deacetylate non-histone 
targets that are essential for early development. For 
example, SIRT1 deacetylates HSF1 to enhance its 
activity [42], and maternal HSF1 is required for 
development beyond the zygote stage [43]. Therefore, 
high expression of SIRT1 may work together with 
HSF1 during early development. 
 
However, SIRT1 is not absolutely required during early 
development. Loss of SIRT1 on an outbred genetic 
background allows for 50% of SIRT1
-/- mice to develop 
relatively normally [11]. Importantly, other SIRT1 null 
mouse models show that SIRT1
-/- mice are not obtained 
at expected ratios with the majority of SIRT1
-/- mice 
dieing right after birth [10] or between E9.5 and E14.5 
[44]. It is possible that another deacetylase, namely 
HDAC1, which is also both highly expressed in mESCs 
(Figure 1A) and upregulated during reprogramming 
(Figure 6A), partially compensates for SIRT1. In 
support of this idea, many non-histone targets are 
deacetylated by both SIRT1 and HDAC1 including p53 
and NF- κB [4]. 
 
At least in lower organisms, SIRT1 regulates lifespan, 
and several genes that regulate lifespan also maintain 
genomic integrity in germ cells and stem cells [8]. A 
possible role of SIRT1 in mESCs and during early 
development could be to monitor quality control of 
developing embryos. SIRT1 may respond to oxidative 
stress, genotoxic damage, metabolic defects, and 
epigenetic reprogramming errors, possibly through the 
deacetylation of p53 and other targets, to regulate 
survival of developing embryos. Indeed, expression 
level and activity of p53 in early pre-implantation 
embryos regulates their viability [45].  
 
Another intriguing question is whether downregulation 
of SIRT1 is necessary during differentiation and 
development. SIRT1 may be downregulated during 
differentiation in a manner similar to other stress 
defense mechanisms that are highly active in ESCs [2]. 
The downregulation of SIRT1 via a post-transcriptional 
mechanism allows its mRNA to persist and might allow 
SIRT1 expression to be rapidly induced during stress 
when energy intensive cell repair and survival 
mechanisms are required. The decrease of SIRT1 
protein levels observed during aging may conserve 
energy but may also contribute to increased genomic 
instability [46].  
 
Loss of miRNAs might contribute to the overexpression 
of SIRT1 in cancer. For example, loss of miR-34a leads 
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results point to direct binding of miR-34a to the SIRT1 
3'-UTR whereas others have suggested indirect 
regulation of SIRT1 by miR-34a [47-48]. Several other 
miRNAs that target SIRT1 are lost in cancers. For 
example, miR-181a and b function as tumor 
suppressors in the brain, but their loss negatively 
correlates with glioma grade, and restoration of their 
expression induces apoptosis of glioma cells [49]. 
Furthermore, miR-181 and miR-29 family members 
are downregulated in chronic lymphocytic leukemia, 
and miR-29 is lost in colon, breast, and lung cancer 
[50-53]. While SIRT1 may function as a tumor 
suppressor by limiting replicative senescence in 
primary cells, SIRT1 overexpression is seen in many 
cancers where it may promote cell survival [4]. 
Reintroduction of miRNAs lost in cancers that 
overexpress SIRT1 may be of therapeutic value 
against cancers dependent on the overexpression of 
SIRT1. 
 
Our findings that miRNAs regulate SIRT1 expression 
suggest that inhibiting specific miRNAs may be of 
therapeutic value in disease conditions where SIRT1 
activity has been shown to be beneficial such as 
diabetes, neurodegeneration, and cancer [54]. Currently 
available small molecule SIRT1 activators and 
inhibitors globally increase or inhibit SIRT1 activity. In 
contrast, the use of tissue-specific miRNA mimics or 
inhibitors may allow for the tissue-specific regulation of 
SIRT1 to prevent and treat age-related diseases without 




Culturing and differentiation of mESCs. E14 mESCs 
[55] were cultured feeder-free in Glasgow 
MEM/BHK12 (GMEM; Sigma-Aldrich; St. Louis, MO) 
supplemented with 10% characterized fetal bovine 
serum (FBS; Hyclone; Logan, UT), 2 mM L-glutamine 
(GIBCO Invitrogen Corporation; Carlsbad, CA), 1 mM 
sodium pyruvate (GIBCO Invitrogen Coroporation), 0.5 
mM  β-mercaptoethanol (Sigma), and leukaemia 
inhibitory factor (LIF) conditioned medium on plates 
coated with 0.1% bovine gelatin (Sigma) in PBS. 
Undifferentiated ESCs were passaged every 2 days, and 
medium was changed on alternate days. Differentiation 
was induced by plating 3x10
6 cells in 10-cm, ultra-low 
attachment dishes (Corning; Lowell, MA) in 10 ml of 
differentiation medium (GMEM supplemented with 
15% FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 
and 0.5 mM β-mercaptoethanol). Medium on the 
embryoid bodies was changed every 2 days. The 
proteasome inhibitor MG-132 (10 μM; Calbiochem; 
Darmstadt, Germany) was added to the media of d8 
embryoid bodies for the indicated times. 
For neuronal differentiation, 5 μM retinoic acid (Sigma  
R-2625) was added to d4 embryoid bodies [56]; then d8  
embryoid bodies were trypsinized to form a single-cell 
suspension. Cells were strained through a 40-μM nylon 
mesh (BD Biosciences; San Jose, CA), and 8x10
5 cells 
in 1 ml of neurobasal A (NBA) medium (Invitrogen) 
supplemented with 2% B27 supplement (Invitrogen) 
and 500 μM glutamine were plated onto poly-D-
lysine/mouse laminin 12-mm coverslips (BD 
Biosciences) in 24-well plates. Medium was changed 2 
and 24 h after plating. After 2 days, the medium was 
changed to NBA supplemented with 1% N2 
(Invitrogen) and 500 μM glutamine.  
 
Expression constructs. The full-length 1.6 kb mSIRT1 
3'-UTR was PCRed from IMAGE clone 3587177 (Open 
Biosystems; Huntsville, AB) with primers that add NheI 
sites (underlined): forward, 5'-TCATAACGCTAGCGA 
AGCTGTCCG-3'; reverse, 5'-TCCAGTCATTAAACG 
GGCTAGCAAAC-3'. This SIRT1 3'-UTR was cloned 
behind luciferase in the pGL3-promoter vector 
(Promega; Madison, WI) digested with XbaI. Site-
directed mutagenesis was performed using a 
QuikChange II Site-Directed Mutagenesis kit 
(Stratagene; La Jolla, CA) to mutate base pairs 3–6 in 
the predicted seed region targeted by miR-181 and miR-
9 in the SIRT1 3'-UTR. 
 
Genomic DNA 250–350 bp on either side of the 
genomic locus for miR-181a and b, miR-9, miR-204, 
miR-135a, and miR-199b was amplified and cloned into 
pCDNA/V5-DEST (Invitrogen) with the following 
primers: mmu-miR-181a and mmu-miR-181b amplified 
from chromosome 1 (5'-CACCAACAGCCTGTAACT 
AAGCTCC-3' and 5'-TGATTCTGGGCATCCAACAC 
-3'), mmu-miR-9-2 amplified from chromosome 13 (5'-
CTAGCCGCACACACTAAG-3' and 5'-TGCATCCCA 
CTTTCAATCATA-3'), mmu-miR-204 amplified from 
chromosome 19 (5'-CACCTTCATTCAGCACCTAGT 
TGAG-3' and 5'-ATACATTACAACCTGTTCAGAGG 
-3'), mmu-miR-199b amplified from chromosome 2 (5'-
CCACAGGAGGCAGAAGGGGAGTCG-3' and 5'-
CCCATCAGCCCAGCCATTTGC-3'), and mmu-miR-
135a amplified from chromosome 9 (5'-CACCTCAG 
TGTCCAATGGGAATAC-3' and 5'-GGCTATCAAGG 
GGTTTCTTCAGG-3'). miR-1 was cloned as described 
[57]. 
 
Western blot analysis.  mESCs, Embryoid bodies, and 
neurons were lysed in 50 mM Tris-HCl (pH 7.5), 0.5 
mM EDTA, 150 mM NaCl, 0.5% NP-40, and 1x 
complete protease inhibitors (Roche; Penzberg, 
Germany), and protein concentrations were determined 
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from ~6-week-old mice were lysed (0.1 g/ml) in 50 mM 
Tris-HCl (pH 7.5), 0.5 mM EDTA, 500 mM NaCl, 
0.5% NP-40, and 1x complete protease inhibitors 
(Roche) with a Dounce homogenizer. Protein samples 
were separated by electrophoresis on 7.5% or 10% 
SDS-polyacrylamide gels and transferred to 
nitrocellulose membranes (Bio-Rad). Membranes were 
blocked with 5% nonfat dry milk in TBS-Tween [10 
mM Tris-HCl (pH 7.5), 150 mM NaCl, and 0.1% 
Tween-20] and probed with antiserum against HDAC1 
[58], HDAC2 (Santa Cruz #7899), SIRT1 (polyclonal 
antiserum to amino acids 506-747 of hSIRT1 or 
Millipore #07-131), GAPDH (Novus Biologicals; 
Littleton, CO), Actin (Sigma), HDAC4 [59], Tau (EMD 
Biosciences; Germany), Nestin (Millipore; Billerica, 
MA), Oct-3/4 (R&D Systems), Nanog (Cosmo Bio; 
Tokyo, Japan), REST (Millipore), DGCR8 (Proteintech; 
Chicago, IL) and α-tubulin (Sigma). 
 
Quantitative RT-PCR.  Total  RNA was isolated using 
TRIzol (Invitrogen). 1 μg of RNA was reverse 
transcribed into cDNA with Superscript II or III 
(Invitrogen) and oligo dT. Relative expression levels 
were determined by real-time quantitative PCR in an 
ABI 7700 or 7900 and normalized to GAPDH. 2X 
HotSybr Real-time PCR mix (McLab; South San 
Francisco, CA) was used with validated primers for 
HDAC1 (PPM04372A), HDAC2 (PPM04361A), and 
SIRT1 (PPM05054A; SuperArray Bioscience; 
Frederick, MD). GAPDH was amplified using (forward: 
5'-ACTCCACTCACGGCAAATTCA, reverse: 5'-
GCCTCACCCCATTTGATGTT), Oct-3/4 was 
amplified using (forward: 5'- TCAGCCTTAAGAACA 
TGTGTAAGC, reverse: 5'- GTCTCCGATTTGCATAT 
CTCC), and Dicer was amplified using (forward 5'- 
TGGGAGATGCGATTTTGGA, reverse: 5'- GCTGCC 
GTGGGTCTTCATAA). 2X HoTaq Real-time PCR 
mix (McLab) was used with validated primers from 
Applied Biosystems for Nestin (Mm00450205_m1), 
SIRT1 (Mm_00490758_m1), FoxA2 (Mm01976556_ 
s1), and Map2 (Mm00485230_m1). 
 
Relative miRNA expression levels were quantified 
using the NCode miRNA first-strand cDNA synthesis 
kit (Invitrogen) to add a polyA tail onto the miRNAs. 
qPCR was performed using a forward primer to the 
exact sequence of the target miRNA and a reverse 
primer provided in the NCode kit. cDNA and qPCR 
reactions were generated using validated primers 
(Applied Biosystems) for hsa-miR-16 (4373121), has-
miR-181a (4373117), hsa-miR-9 (4373285), has-miR-
204 (4373313), has-miR-199b (4373309), has-miR-
135a (4373140), and hsa-miR-1 (4395333).  
AAV8 vector preparation and adenovirus infection. The 
double-stranded AAV8 vector for the expression of Cre 
from the transthyretin promoter was described (Amar 
Deep Sharma et al., manuscript submitted). Briefly, 
A293 cells were transfected with the AAV vector 
plasmid, the adenoviral helper plasmid pAd5, and the 
AAV8 capsid expression plasmid p5E18-VD2/8 [60] by 
the calcium phosphate method. Virus was collected 72 h 
after transfection and concentrated by centrifugation on 
cesium chloride density gradients. Viral titer was 
determined by dot blot analysis. Viral particles (2 x 10
11 
in 100 µl) were injected into the tail vein of Dicer
flox/flox 
mice [11]. Livers were harvested 72 h, 1 wk, and 2 wk 
after virus injection. 
 
Lungs from Dicer
flox/flox mice were cut into small pieces 
and adhered to tissue culture plates in DMEM. 
Fibroblasts that grew out of the explants were collected 
and 80,000 lung fibroblasts were seeded in 1ml of 
DMEM into a 12-well plate. 24 h later, adenovirus 
expressing GFP or Cre was added at an MOI=100 to 
500 μl of fresh DMEM in each well. Protein and RNA 
were isolated 72 h later. 
 
siRNAs, miRNA mimics, and LNA probes. 20,000 
NIH3T3 cells were plated per well of a 12-well plate in 
1 ml of DMEM with 10% bovine calf serum without 
antibiotics 24 h before transfection. siGENOME 
SMARTpool siRNAs (10 nM) against DGCR8, Dicer, 
or GL3 luciferase (Thermo Scientific) were added to 
100  μl of OptiMem. Lipofectamine RNAiMax (2 μl) 
(Invitrogen) in 98 μl of OptiMem was mixed with the 
siRNA for 20 min. This 200-μl solution was added 
along with 800 μl of fresh medium to each well. Protein 
and RNA were isolated at indicated time points. 
 
miRNA mimics in the form of siRNA duplexes 
(Thermo Fisher Scientific; Waltham, MA) for mmu-
miR-181a (C-310047-04), mmu-miR-181b (C-310182-
05), mmu-miR-181c (C-310183-02), the microRNA 
mimic negative control (CN-001000-01), and FITC-
conjugated miRCURY LNA knockdown probes 
(Exiqon; Woburn, MA) antisense to mmu-miR-9 (LNA-
miR-9; 139459-04) or scramble control (LNA-SCR; 
199002-04) were transfected into mESCs or embryoid 
bodies using lipofectamine 2000 (Invitrogen). Embryoid 
bodies were transfected by trypsininzing embryoid 
bodies to single-cell suspensions. 700,000 cells in 600 
μl of medium were added to complexes containing 4 μl 
of the 25 μM LNA probe and 5 μl Lipofectamine 2000 
in 300 μl of OptiMem. The cells were plated in 24-well 
ultra-low-attachment plates, and after 30 min, 750 μl of 
medium was added. 
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5 in 300 μl of medium) were added to 
complexes containing 1.6 μg of pCDNA miRNA expres-
sion vectors and 3 μl of Lipofectamine 2000 (Invitrogen) 
in 150 μl OptiMem. The cells were plated on gelatinized 
12-well plates, and 1.5 ml of medium was added after 30 
min, and medium was changed the next day.  
 
Luciferase assays. mESCs (150,000 in 1 ml of medium) 
were added to gelatinized 24-well plates and 
immediately transfected using 1 μl Lipofectamine 2000 
(Invitrogen) with 20 ng Renilla luciferase as an internal 
control, 200 μg pGL3-SIRT1 3'-UTR or vectors with 
mutated seed sites, and 20 pmol (~300 ng) of the 
miRNA mimics or 200 ng of an miRNA expression 
construct. After 24 h, cells were washed in 1X PBS, 
lysed at room temperature for 15 min in 100 μl of 1X 
passive lysis buffer (Promega), and 20 μl of the lysate 
was used in a dual luciferase assay (Promega) in a 
Monolight 2010 luminometer (Analytical Luminescence 
Laboratory; San Diego, CA). Results were normalized 
to Renilla and are shown relative to samples 
cotransfected with a negative control miRNA or empty 
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by  treatment  with  retinoic  acid  and  plating  on  poly‐D‐
lysine/laminin coated plates. 
Supplementary  Figure  2.  SIRT1  is  not  post‐transcrip‐
tionally  regulated  by  the  proteasome  during  mESC 
differentiation. d8 EBs were treated for the indicated times 
with  the  proteasome  inhibitor  MG‐132  and  analyzed  by 
western blotting for expression of REST, SIRT1, and tubulin. 
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miR-9 345-351  95  0.97  5000 
miR-22 475-481 99  0.95  <2 
miR-29a 549-555  54  -  4 
miR-29b 549-555  64  -  <2 
miR-29c 549-555  65  -  30 
miR-30a-5p 72-78  74  0.67  180 
miR-30b 72-78  72  0.67  180 
miR-30c 72-78  72  0.67  160 
miR-30d 72-78  74  0.67  280 
miR-30e 72-78  81  0.84  300 
miR-34a  781-787, 1277-1283  42, 38  -  <2 
miR-34c  781-787, 1277-1283  38, 38  -  <2 
miR-124a 1068-1074  36  0.96  5 
miR-128 744-750  84  0.92  600 
miR-129-5p  61-67, 1217-1223  37, 64  -  <2 
miR-132 1450-1456  86  0.74  130 
miR-135a 304-310  81  0.88  180 
miR-135b 304-310  82  0.88  55 
miR-138 35-41  95  0.98  <2 
miR-141 1562-1568  96  0.87  <2 
miR-153 797-803  29  0.76  6 
miR-181a 68-74  86  0.81  300 
miR-181a 68-74  86  0.81  300 
miR-181a 68-74  84  0.81  4560 
miR-186 1243-1249  57  -  <2 
miR-199a 451-457  87  0.95  50 
miR-199b 451-457  88  0.95  560 
miR-200a 1562-1568  96  0.73  <2 
miR-200b  1143-1149, 1293-1299  68, 17  -  <2 
miR-200c  1143-1149, 1293-1299  68, 17  -  <2 
miR-204 325-331  94  0.82  1300 
miR-211 325-331  94  0.83  200 
miR-212 1450-1456  91  0.74  <2 
miR-217 1355-1361  98  0.77  <2 
miR-369-3p  110-116, 999-1005  87, 27  0.82, 0.82  <2 
miR-429  1143-1149, 1293-1299  64, 20  -  4 
miR-448 796-802  81  0.88  10 
miR-449a  781-787, 1277-1283  54, 45  -  <2 
miR-543  69-75, 313-319  95, 91  0.85, 0.85  <2 
The miRNAs listed are predicted to target SIRT1 and their expression was profiled during mESC differentiation 
 
Supplemenary Figure 3. miR‐199 is highly expres‐
sed in mouse embryonic fibroblasts and skin. qRT‐
PCR analysis of miR‐199a and b expression relative to
miR‐16 in mESCs, MEFs, and various mouse tissues. Data
are mean ± s.d. for four samples. 